Chemical control of multidomain acetyltransferase activity.
暂无分享，去创建一个
[1] Christopher J. Ott,et al. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. , 2020, Cell chemical biology.
[2] C. Crews,et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. , 2020, Cell chemical biology.
[3] A. Mapp,et al. Selective Modulation of Dynamic Protein Complexes. , 2020, Cell chemical biology.
[4] Melinda M. Mulvihill,et al. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity , 2020, ChemMedChem.
[5] S. Conway,et al. Chemische Epigenetik: der Einfluss chemischer und chemo‐biologischer Techniken auf die Zielstruktur‐Validierung von Bromodomänen , 2019, Angewandte Chemie.
[6] J. Brickman,et al. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome , 2018, Cell.
[7] Chunaram Choudhary,et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours , 2017, Nature.
[8] Mariko Sasaki,et al. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression. , 2016, Cancer discovery.
[9] Philip A. Cole,et al. Protein Lysine Acetylation by p300/CBP , 2015, Chemical reviews.